| 产品名称 | 产品编号 | CAS编号 | 分子式 = 分子量 | 位单 | 联系QQ |
| 人参皂苷Rk1; Ginsenoside Rk1 | CFN92644 | 494753-69-4 | C42H70O12 = 767.0 | 20mg | QQ客服：3257982914 |
| 人参皂苷Rg5; Ginsenoside Rg5 | CFN92643 | 186763-78-0 | C42H70O12 = 767.0 | 10mg | QQ客服：215959384 |
| 3,5-二甲氧基-4-羟基肉桂酸，芥子酸; Sinapic acid | CFN92631 | 530-59-6 | C11H12O5 = 224.2 | 20mg | QQ客服：1457312923 |
| L-精氨酸; L-Arginine | CFN90550 | 74-79-3 | C6H14N4O2 = 174.20 | 20mg | QQ客服：2159513211 |
| 桉叶油醇; Cineole | CFN90545 | 470-82-6 | C10H18O = 154.25 | 20mg | QQ客服：215959384 |
| 乙酰基-11-酮基-beta-乳香酸; 3-O-Acetyl-11-keto-beta-boswellic acid | CFN90531 | 67416-61-9 | C32H48O5 = 512.72 | 20mg | QQ客服：215959384 |
| 槲皮素3-O-芸香糖苷; Quercetin-3-o-rutinose | CFN92447 | 949926-49-2 | C27H30O16 = 610.5 | 5mg | QQ客服：2056216494 |
| 3-O-阿魏酰奎尼酸; 3-O-Feruloylquinic acid | CFN92393 | 1899-29-2 | C17H20O9 = 368.3 | 5mg | QQ客服：2056216494 |
| 4-O-阿魏酰奎尼酸; 4-O-Feruloylquinic acid | CFN92392 | 2613-86-7 | C17H20O9 = 368.3 | 10mg | QQ客服：215959384 |
| 山奈酚3-O-beta-D-槐糖苷; Kaempferol 3-O-beta-sophoroside | CFN92372 | 19895-95-5 | C27H30O16 = 610.5 | 20mg | QQ客服：1413575084 |
| 桦褐孔菌醇; Inotodiol | CFN92367 | 35963-37-2 | C30H50O2 = 442.7 | 5mg | QQ客服：2056216494 |
| 反式石竹烯; trans-Caryophyllene | CFN90502 | 87-44-5 | C15H24 = 204.36 | 20mg | QQ客服：2159513211 |
| 单宁酸; Tannic acid | CFN90501 | 1401-55-4 | C76H52O46 = 1701.2 | 20mg | QQ客服：1413575084 |
| 诃子林鞣酸; Chebulinic acid | CFN92296 | 18942-26-2 | C41H32O27 = 956.7 | 20mg | QQ客服：1457312923 |
| Delta 7-avenasterol; Delta 7-avenasterol | CFN92240 | 23290-26-8 | C29H48O = 412.7 | 5mg | QQ客服：2159513211 |
Cell. 2018 Jan 11;172(1-2):249-261.e12. doi: 10.1016/j.cell.2017.12.019.IF=36.216(2019)
Cell Metab. 2020 Mar 3;31(3):534-548.e5. doi: 10.1016/j.cmet.2020.01.002.IF=22.415(2019)
Mol Cell. 2017 Nov 16;68(4):673-685.e6. doi: 10.1016/j.molcel.2017.10.022.IF=14.548(2019)
ACS Nano. 2018 Apr 24;12(4): 3385-3396. doi: 10.1021/acsnano.7b08969.IF=13.903(2019)
Nature Plants. 2016 Dec 22;3: 16206. doi: 10.1038/nplants.2016.205.IF=13.297(2019)
Sci Adv. 2018 Oct 24;4(10): eaat6994. doi: 10.1126/sciadv.aat6994.IF=12.804(2019)